<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137388">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01312649</url>
  </required_header>
  <id_info>
    <org_study_id>4880</org_study_id>
    <nct_id>NCT01312649</nct_id>
  </id_info>
  <brief_title>Feeling of Being in Control of One's Own Action</brief_title>
  <official_title>Feeling of Being in Control of One's Own Action: Which Mechanisms in Healthy Volunteers and in Mental Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim is to understand the cognitive mechanisms that contribute to the
      emergence of delusions of control (the belief that one's own actions or thoughts are
      controlled by an external force). These symptoms are mainly encountered in patients with
      schizophrenia, and the investigators will distinguish patients with schizophrenia with or
      without this symptom together with patients with bipolar disorder. Based on the
      investigators previous studies, this project will help to determine the role of two
      elementary mechanisms in the ability to feel in control of voluntary actions: (1) the
      processing of the sensory consequences of action, and (2) the ability to build mental
      representations for sequenced actions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">370</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Bipolar Disorders</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Schizophrenia with history of delusions of control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Schizophrenia without history of delusions of control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bipolar disorders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Matched healthy controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Experimental psychology methods (computer tests)</intervention_name>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_label>Arm 4</arm_group_label>
    <arm_group_label>Arm 5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with schizophrenia or bipolar disorders (criteria DSM IV) or healthy
             controls matched with patients on age, sex and education level

          -  18-55 years old

        Exclusion Criteria:

          -  Past history affecting CNS

          -  Invalidating sensory disorders

          -  Intake of psychotropic drugs, except for patients

          -  Intake of benzodiazepines
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne GIERSCH, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Giersch</last_name>
    <phone>3.33.88.11.64.71</phone>
    <email>giersch@alsace.u-strasbg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pôle de Psychiatrie - Hôpital civil</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne GIERSCH, MD</last_name>
      <phone>3.33.88.11.64.71</phone>
      <email>giersch@alsace.u-strasbg.fr</email>
    </contact>
    <investigator>
      <last_name>Gilles BERTSCHY, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence LALANNE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastien WEIBEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne GIERSCH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 15, 2016</lastchanged_date>
  <firstreceived_date>March 1, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
